Allergy

Pharmacists should understand their mechanisms to facilitate high-quality, collaborative management with physicians.

Rx products features in the April 2020 issue.

Over-the-counter products featured in the April 2020 issue of Pharmacy Times.

Researchers have found that approximately 1% of children have an allergy to cow’s milk, but up to 14% of families believe their children may have the condition, pointing to official guidelines for detecting cow’s milk allergy as a possible cause for the overdiagnosis.

Aimmune’s peanut allergen power was approved by the FDA as an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanut.

The FDA has approved olopatadine hydrochloride ophthalmic 0.1% and 0.2% solution for sale as an OTC medication in the United States.

The once-daily solution will be the first once-daily eye-itch allergy-relief drop to be available without a prescription in the United States.

Treatment with this peanut immunotherapy consists of 3 phases: Initial Dose Escalation, Up-Dosing, and Maintenance.

A pharmacy-driven assessment found more than half of patients with reported penicillin allergies were able to take antibiotics from the same drug class, rather than resorting to substitutes that may have downsides.

Home remedies or medical intervention? Cause and symptoms dictate type of treatment.

The product to treat life-threatening allergies arrives amid the ongoing supply shortage.

Back-to-school season is a time of great excitement as millions of students start a new year. It also presents challenges for those who suffer from seasonal allergies.

Finding solutions to allergic conjunctivitis.

Treating allergic rhinitis, including itchy eyes and a sore throat.

With allergy symptoms still lingering and summer just around the corner, the list of top-recommended over-the-counter products helps consumers and their families stay healthy during any getaway.

Positive results were collected from a Phase 3 study of an investigational fixed-dose combination nasal spray for the treatment of seasonal allergic rhinitis (SAR), according to Glenmark Pharmaceuticals.

Why is this patient listing ciprofloxacin as an allergy?

Pharmacists have a great opportunity to educate patients about how to stay healthy and counsel those in need of symptom relief about their allergy treatment options.

Pharmacists can provide easily accessible and economically reasonable solutions for patients who suffer from allergies.

Dupilumab is now the first biologic therapy approved for the patient population.

Inhaler misuse may result in more asthma attacks.

Future studies will help us determine who will most benefit from egg oral immunotherapy.

The needed-free treatment option, ARS-1, is designed to be easy-to-use, convenient and more reliable than other emergency epinephrine treatments for severe allergic reactions.

Teva’s Epinephrine Injection May Not Undercut Mylan’s on Price, but It Could Help in Addressing Shortages

Nasal congestion can negatively affect quality of life by interfering with day-to-day activities and disrupting sleep patterns.

A pair of pivotal Phase 3 placebo-controlled trials that evaluated dupilumab (Dupixent, Sanofi and Regeneron) for adults with inadequately-controlled chronic rhinosinusitis with nasal polyps met all primary and secondary endpoints.

National Penicillin Allergy Day highlights negative impact of Inaccurate allergy diagnoses.

One lot of Montelukast Sodium Tablets is being voluntarily recalled by Camber Pharmaceuticals, due to a safety risk for consumers.

The FDA has approved the first generic epinephrine auto-injector for the emergency treatment of allergic reactions, including anaphylaxis.